| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.5 | 2e-29 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.47 | 8e-26 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.36 | 2e-17 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.35 | 1e-15 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.35 | 6e-15 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.32 | 1e-14 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-14 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.33 | 6e-14 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-13 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-13 |